๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cancer research 2000: drug resistance, new targets and drugs in development

โœ Scribed by Henk J. Broxterman; Nafsika Georgopapadakou

Book ID
119763701
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
164 KB
Volume
3
Category
Article
ISSN
1368-7646

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Drug Resistance in Leishmania Parasites
Drug Resistance in Leishmania Parasites || Drug Targets, Drug Effectors, and Drug Targeting and Delivery
โœ Ponte-Sucre, Alicia; Diaz, Emilia; Padrรณn-Nieves, Maritza ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Springer Vienna ๐ŸŒ German โš– 339 KB

One of the main problems concerning therapeutic tools for the treatment of parasitic diseases, including leishmaniasis, is that some field parasites are naturally resistant to the classical drugs; additionally, current therapies may select parasites prone to be resistant to the applied drugs. These

Antimalarial Drug Development and New Ta
Antimalarial Drug Development and New Targets
โœ I Macreadie; H Ginsburg; W Sirawaraporn; L Tilley ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 314 KB
Targeting mitochondrial permeability in
Targeting mitochondrial permeability in cancer drug development
โœ Michael V. Berridge; Patries M. Herst; Alfons Lawen ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 360 KB

## Abstract The past decade has seen the emergence of a new mechanistic paradigm of cancer therapeutics. Not only have mitochondria taken centre stage as key cellular organelles mediating intrinsic pathways of cell death by apoptosis, but nonapoptotic pathways have also been shown to involve mitoch